GV Investment Managers

Merida Biosciences is a new biotech company focused on developing precision treatments, particularly for autoimmune diseases. The company utilize a protein engineering platform to create unique Fc therapeutics, aiming to selectively bind to specific antibodies.

Lawhive Associates offers legal services in civil and criminal matters, international arbitration, dispute resolution, and defamation cases.

Tessl transforms software development for the AI era with its innovative AI-native development approach. Its AI-powered development platform provides secure, high-quality, and self-maintaining code tailored to the user's requirements.

Odyssey operates as an AI start-up, provides hollywood-grade visual AI.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Again operates as a developer of advanced emission control technology that transforms carbon dioxide into valuable chemicals and proteins through a proprietary bacterial process. The company captures CO2 emissions from industrial facilities within a bioreactor, where the bacteria convert the greenhouse gas into products like feed for poultry and aquaculture. This innovative approach not only helps clients reduce their environmental impact but also allows them to avoid costly emission taxes. As a pioneer in carbon negative manufacturing, Again is positioned to meet global demand for sustainable chemical solutions while actively contributing to the fight against climate change.

Climate X is a global company specializing in climate physical risk data analytics, catering to major financial institutions in banking, real estate, and insurance. The firm focuses on climate risk management services, aimed at projecting and predicting the impacts of climate change and extreme weather events. By integrating advanced climate models with current real-world data, Climate X employs physical modeling techniques to evaluate various scenarios. This approach enables businesses and governments to proactively address and adapt to incoming regulatory requirements related to climate risks.

Verse provides software for organizations to understand, plan, and manage clean energy. Its SaaS platform, Aria™, leverages generative AI to help companies define clean energy goals and plan, procure, and manage optimal portfolios of clean energy assets at least cost. Customers can set parameters that target specific goals (e.g., cost, emissions, or hourly matching) and optimize for annual matching, emissions matching, or hourly matched carbon-free energy (CFE). By reducing transaction costs by up to 70% and providing real-time analysis within minutes, Aria helps scale and accelerate the clean energy transition.

WitnessAI is dedicated to creating a security platform that provides essential governance and security controls for enterprises adopting artificial intelligence. The platform enhances visibility and privacy regarding AI activities, allowing businesses to leverage the benefits of generative AI while maintaining control over their data and ensuring security. By focusing on making AI safe and productive, WitnessAI helps organizations innovate without compromising on privacy or governance.

Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells. It studies cancer-driving pathways and their effect on creating cancer medicines. Delphia Therapeutics is based in Boston, USA.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Monzo is a digital bank designed for individuals who prefer managing their finances through smartphones rather than traditional banking methods. The bank's app provides real-time updates on spending, categorizes transactions, and includes budgeting tools, allowing users to track their financial activities effortlessly. Notable features include "Pots," which enable users to allocate funds for specific goals, and a premium service called "Monzo Plus," which offers enhancements like custom card designs and travel insurance. Monzo's platform also provides instant notifications for transactions and updates account balances without delay, helping users manage their finances effectively without incurring usage fees.

Lapse is a social disposable camera app. The app lets close groups recreate the magic of old-school disposable cameras by taking 36 snaps to ‘rolls’ in private group chats.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

Granata Bio is a biotechnology company established in 2018, dedicated to identifying and developing therapeutics for fertility patients. The company focuses on creating a comprehensive portfolio of fertility treatments and possesses expertise in commercialization, late-stage clinical trials, and regulatory development. Granata Bio aims to address significant challenges faced by medical professionals in the field of fertility treatment. Recently, the company announced a collaboration with IBSA Institut Biochimique to co-develop a novel subcutaneous progesterone solution, further enhancing its commitment to advancing fertility care.

FlutterFlow, established in 2020, is an innovative low-code visual development platform that facilitates the creation of native mobile and web applications. With a user base exceeding 400,000 and a multitude of applications launched in app stores, FlutterFlow enables product teams to design impressive user interfaces and generate clean code efficiently. The platform features a one-click deployment option that accelerates project timelines while allowing for custom code extensions. It supports seamless integration with Firebase and provides a no-code tool for downloading generated Flutter code, making it easier for developers to create cross-platform applications swiftly. By streamlining the application development process, FlutterFlow helps businesses scale rapidly and effectively.

Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company is creating a profiling and engineering technology platform that leverages advanced artificial intelligence to deliver an in-depth understanding of the epigenome in both health and disease. This innovative approach allows healthcare providers to explore new avenues for therapy discovery and facilitates the reprogramming of cells to restore their healthy state. By integrating AI-driven insights, Moonwalk Biosciences aims to transform the landscape of therapeutic development and improve patient outcomes.

Tome Biosciences is a biotechnology company specializing in programmable gene insertion technology. Utilizing CRISPR, the company develops methods to insert genetic sequences of any size at various locations within any genome. This innovative approach aims to enhance the ability to detect and eliminate deoxyribonucleic acid from similar bacteriophages during infections. By advancing cell and genome engineering, Tome Biosciences seeks to provide effective therapeutic solutions for patients, paving the way for significant advancements in genetic medicine.

Gate Bioscience specializes in a small molecule modality to treat biology’s intractable diseases.

Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly during menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancer, and menstrual problems through a clinical platform that delivers personalized care protocols. These protocols are administered by clinicians who are trained in female midlife health. Midi Health enhances its services by utilizing specialized at-home labs, providing prescription medications, supplements, and lifestyle coaching. This comprehensive approach aims to empower women to manage the challenges they face during critical stages of their lives and careers.

Optiwatt is a developer of a monitoring application that helps electric vehicle (EV) owners understand the costs associated with charging their vehicles at home. The platform connects home electricity rate data with EV battery metrics, allowing users to see the cost of each charge and track their electric utility expenses based on their home address. By providing insights into real-time electricity rates, Optiwatt enables users to forecast their charging costs and calculate the savings achieved by driving electric compared to traditional gasoline vehicles. Additionally, the application aims to alleviate range anxiety by offering charge forecasting features, ensuring users are informed about their charging needs and expenses.

EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.

Resistant AI specializes in fraud prevention software aimed at safeguarding automated financial systems from manipulation and attacks. The company develops solutions that protect vital processes such as online credit scoring, fraud detection, and anti-money laundering systems from organized fraudsters. By focusing on the risks associated with machine learning and artificial intelligence, Resistant AI assists banks, insurance companies, and e-commerce entities in securing their digital transactions. Their technology enables these organizations to implement identity forensics, thereby enhancing the integrity of automated financial services and mitigating the threats posed by advanced fraud.

Delve Bio is a biotechnology company focused on delivering molecular insights to enhance precision patient care. It specializes in the pathogen-agnostic and unbiased detection of neuro-infectious pathogens in cerebrospinal fluid (CSF). By providing comprehensive diagnostic solutions in a single test, Delve Bio equips laboratories and clinicians with critical information necessary for identifying both common and rare infectious diseases, thereby facilitating more accurate and timely medical interventions.

Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need for mental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it.

Bitterroot Bio is a biotechnology company focused on developing innovative immunotherapy-based treatments for cardiovascular disease. By harnessing the immune system's natural capabilities to combat illness, the company conducts research to understand the significant roles of immune cells and immune modulators in the onset and advancement of cardiovascular conditions. Through its commitment to advancing medical treatments, Bitterroot Bio aims to provide effective therapies that can transform cardiovascular disease management and improve patient outcomes.

Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Push Security specializes in cybersecurity software that aims to prevent identity-based attacks. Its browser-based agent monitors how employees create and use identities, generating unique telemetry that can be accessed through the Push platform or integrated with existing security information and event management (SIEM) systems. This allows security teams to oversee their entire identity attack surface and effectively detect and block various identity-based threats, including advanced phishing techniques. Push Security enforces preventive measures that guide employees within their browser, helping to avert potential breaches before they occur. The platform also provides clear guidance for implementing essential security controls, with automation facilitating quicker deployment. This approach enables organizations, particularly small and medium-sized enterprises, to enhance their security measures efficiently and affordably without the need for additional solutions.

EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.

Dope Security is a stealth technology company focused on developing enterprise cybersecurity software that addresses web-based threats. Its innovative platform eliminates the traditional data center architecture used by legacy providers by implementing a fly-direct approach that secures data directly at the endpoint. This method enhances performance while ensuring privacy and reliability for enterprises. The company aims to provide a seamless user experience, making it easier for cybersecurity firms to protect their clients from various online vulnerabilities.

Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

Typeface is a generative AI application for creating enterprise content. Enterprises can now create on-brand content faster combining content velocity with brand personalization and control. It offers self-service content development solutions for the entire lifecycle, allowing every employee to create captivating content with ease, speed, and brand authenticity.

Aera Therapeutics is a biotechnology company focused on enhancing the delivery of genetic medicines through its proprietary protein nanoparticle (PNP) platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that can effectively package and transfer nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to extend the application of genetic medicines across various tissues and disease areas, ultimately benefiting a wider patient population. In addition to its PNP platform, Aera has developed a therapeutic enzyme platform that features novel, compact, and programmable gene-editing enzymes, further advancing its mission to transform the field of genetic medicine.

Superplastic is a character-based product and entertainment company. It creates limited edition art toys, apparel, games, and animation based on characters created in collaboration with some of the greatest artists in the world. Superplastic is founded on the principle that effort and scarcity are intrinsic components of value. The company appropriates the tools of mass media and mass production to create limited edition works of art for a limited audience. It was established in 2017 and is based in Burlington, Vermont.

Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Osmo gives computers a sense of smell that improves the health and well-being of human life. Osmo brings together frontier AI and olfactory science to tackle a historic challenge. While they are initially focused on the intricate world of fragrance, their ultimate objective is to enhance the health and well-being of human life through the sense of smell.

Cacheflow is a zero-code software-as-a-service (SaaS) sales platform that automates the proposal-to-payment process, facilitating a seamless sales experience. Founded in 2021 and based in San Francisco, the company offers a solution that simplifies the SaaS sales flow by integrating various functions into a single platform. Sales teams can quickly generate dynamic quotes and streamline the buying process through features such as simple configuration, interactive checkout, and integrated payment options. Cacheflow's services include self-service checkout, flexible payment plans, and automated billing, all designed to enhance cash flow and improve client relationships, ultimately enabling SaaS businesses to sell more efficiently.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

SideQuest Ltd is a company based in Belfast, United Kingdom, that specializes in developing a virtual reality platform for computer games. Founded in 2020, SideQuest operates as a community-driven app store, providing users with access to early access content in the realm of virtual reality. This innovative platform allows developers to distribute their games directly to users, fostering a collaborative environment for both creators and players within the growing virtual reality ecosystem.

Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

FYTO, Inc. is a company based in Cambridge, Massachusetts, that focuses on developing plant-based feed production systems aimed at enhancing the sustainability of agriculture. Founded in 2019, FYTO specializes in creating nutrient-dense crops that require minimal resources, alongside cultivation and harvesting systems designed to ensure quality and consistency. The company's offerings include a variety of agricultural products such as animal feed, plant-based proteins, nutritional supplements, and bio-fertilizers. By adopting climate-friendly practices and methodologies, FYTO aims to support farmers globally in achieving improved economic and environmental outcomes in their agricultural operations.

Sanas is a technology company that specializes in real-time speech-understanding solutions designed to modulate accents while maintaining the natural quality of voices and emotions. Its platform aids multilingual speakers by offering accent correction, which facilitates effective communication and reduces language barriers. The technology is particularly beneficial for contact centers and enterprises, enhancing overall communication, improving customer satisfaction, and minimizing instances of miscommunication. By enabling users to communicate in their preferred accents without noticeable delays, Sanas fosters better understanding and interaction among diverse speakers.

Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.

Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

Deepset is a company specializing in natural language processing (NLP) solutions, focusing on leveraging the latest advancements in machine learning to create real-world applications. It is known for developing the Haystack open-source framework, which facilitates the deployment of NLP tasks, and for offering deepset Cloud, a platform designed for enterprise AI teams. Since its inception in 2018, deepset has supported numerous AI teams globally by providing reliable, open-source technology and tailored solutions. The company's software emphasizes the use of transfer learning to enhance model performance while minimizing the amount of training data required, thereby enabling users to unlock value from diverse text sources effectively.

Doppler is a company based in San Francisco, California, specializing in application management and secret management solutions for developers. Founded in 2018, its platform enables developers to efficiently manage API keys, credentials, environment variables, and database URLs across various projects and programming languages. By offering secure storage and smart retrieval of sensitive data, Doppler enhances developer productivity while bolstering security measures within organizations. The platform also provides insights into potential security issues, allowing developers and security teams to maintain synchronization and security of application configurations across different devices and environments.

Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.

Gravity Sketch is a London-based company founded in 2014 that specializes in developing virtual reality and 3D design software. Its intuitive multi-platform tools are designed to enhance the efficiency and effectiveness of creating three-dimensional products across various industries, including transportation, industrial design, apparel, and footwear. The platform facilitates the entire design process, allowing users to trace their ideas from initial conception to finalization in an engaging and straightforward manner. By streamlining workflows and fostering collaboration among cross-functional teams, Gravity Sketch aims to reduce friction in traditional design practices, ultimately enabling faster and more cost-effective creative processes.

Rattle is a company that specializes in developing integration technology for Salesforce, facilitating seamless interaction between systems and users within platforms such as Slack and Teams. This revenue orchestration platform caters to all customer-facing departments, allowing sales representatives to log calls, track key metrics, and update opportunities with ease. Additionally, it enables account executives and sales development representatives to maintain customer relationship management systems while providing real-time visibility into pipeline reports. This functionality empowers marketing professionals to focus on engaging with customers rather than managing internal processes. Rattle was co-founded in 2020 by Sahil Aggarwal, Apoorva Verma, and Milan Singh.

Bonnet Ltd. is a London-based company founded in 2019 that specializes in a charging-as-a-service platform for electric vehicle drivers. The company addresses the challenges faced by drivers who must register separately for multiple public charging networks by offering a single app that enables access to any public charger. This streamlined service caters to both individual drivers and businesses, simplifying the charging process and enhancing the overall user experience for electric vehicle owners.

Overview’s inspection systems are built with Deep Learning technology which allows us to find mistakes more consistently and in a wider variety of situations.

Voltron Data specializes in developing tools for data access and memory computing aimed at enhancing the data analytics ecosystem. The company has created an open-source platform that facilitates seamless connections between data, hardware, and developers. By providing modular and composable analytics building blocks, Voltron Data enables the creation of multi-language tools that promote accelerated data interchange and in-memory processing. This approach allows developers, data scientists, and data engineers to improve their toolchains and establish better interoperability standards for data access, preparation, cleaning, analytics, and feature engineering.

Neo.Tax, based in Mountain View, California, offers tax preparation and automation services through its innovative software platform. The company focuses on simplifying the often complex process of applying for the Research and Development (R&D) tax credit, especially in light of recent tax law changes regarding R&D capitalization. By leveraging machine learning algorithms, Neo.Tax automates the collection and organization of data from various sources, including emails, documents, and financial systems, which streamlines the tax filing process. Their platform is designed to assist both early-stage startups and larger public companies, ensuring they are audit-ready and capable of optimizing their tax liability. Through its solutions, Neo.Tax aims to alleviate common challenges faced by finance teams in accurately documenting activities and expenses related to tax credits.

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases. The company uses somatic mosaicism and clonal hematopoiesis (CHIP) to find and develop new treatments for age-related disorders. Foresite Labs co-founded TenSixteen Bio, which is based in San Francisco.

Wonder is a company that operates in two distinct sectors: gaming and food delivery. In the gaming industry, Wonder develops an all-in-one platform specifically for Android mobile devices, enabling users to play, stream, and share games seamlessly across different devices, thus enhancing the overall gaming experience. In the food delivery sector, Wonder runs truck-based restaurants that allow consumers to order food via a mobile app. These trucks are dispatched to locations near users’ homes, where they prepare meals on-site to ensure freshness and quality in deliveries. This dual focus on technology and culinary services positions Wonder uniquely in the market, catering to diverse consumer needs.

Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Patina is a healthcare provider focused on enhancing the aging experience for older adults and their families. The company has developed a care model that prioritizes the unique needs and values of this demographic. By offering personalized and on-demand services, Patina aims to create a healthcare experience that is both human-centered and supportive. This approach allows families to actively participate in the care of their loved ones, ensuring that older adults receive the attention and respect they deserve as they navigate the challenges of aging. Patina's mission is to empower individuals to live their best lives and maintain their dignity as they age.

Modern Age is a health & wellness platform that makes the journey of aging easier, healthier, and manageable by one own self.

Resistant AI specializes in fraud prevention software aimed at safeguarding automated financial systems from manipulation and attacks. The company develops solutions that protect vital processes such as online credit scoring, fraud detection, and anti-money laundering systems from organized fraudsters. By focusing on the risks associated with machine learning and artificial intelligence, Resistant AI assists banks, insurance companies, and e-commerce entities in securing their digital transactions. Their technology enables these organizations to implement identity forensics, thereby enhancing the integrity of automated financial services and mitigating the threats posed by advanced fraud.

Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Matter is a social reading app for articles, blogs, and newsletters to help users find better content online.

Vareto is a modern financial planning and analysis platform tailored for strategic finance and business teams, facilitating company planning, reporting, and operational decision-making. Designed for high-growth and enterprise organizations, Vareto provides a customizable and scalable solution that evolves with business needs. Its platform includes automated reporting tools, planning and modeling features, data visualization capabilities, and comprehensive integration of company management functions. By streamlining reporting processes and enhancing collaboration, Vareto empowers executives to make more informed, data-driven decisions to improve business outcomes.

Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.

Nym transforms revenue cycle management by fully automating the medical coding process. Our engine deciphers clinical language in patient charts and accurately assigns medical charge codes in seconds and with zero human intervention. By automating medical coding with Nym, healthcare providers can improve coding quality while significantly reducing the time and cost associated with medical coding. This ultimately ensures clinical and administrative teams can spend more time focused on patient care.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.

Nearby is a computer software company that facilitates connections between local businesses and nearby customers. The company provides a platform that enables merchants to showcase their inventory online, effectively bringing their products into a digital marketplace tailored to their local community. By generating demand and fulfilling orders through targeted email campaigns, local delivery, and nationwide shipping, Nearby empowers local merchants to enhance their visibility and grow their customer base.

Treeline Biosciences is a biotechnology company established in 2021 and based in Stamford, Connecticut. The company focuses on developing transformative precision medicines aimed at treating cancer and other serious health conditions. Utilizing a comprehensive drug discovery platform, Treeline combines mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science to create innovative therapeutic solutions. Through its research and development efforts, Treeline aims to provide effective treatments to improve patient outcomes in oncology and beyond.

Leyden Labs is focused on developing intranasal products that aim to protect individuals from respiratory viruses, including those in the influenza and coronavirus families. The company's innovative approach targets common characteristics across various viral families, allowing for simultaneous protection against multiple viruses rather than just specific variants, as is the case with traditional vaccines. This strategy seeks to empower individuals to safeguard themselves from infections and reduce the transmission of these diseases. Leyden Labs is driven by a team of experienced biotechnology professionals who are committed to advancing solutions that alleviate the impact of respiratory viruses on public health.

nPlan Limited specializes in artificial intelligence-driven software for construction project management. Established in 2017 and based in London, the company develops a platform that leverages machine learning to enhance schedule certainty by identifying risks and suggesting optimal execution paths. Its technology analyzes an extensive dataset of construction schedules, enabling clients to understand uncertainties and risks associated with their projects. By detecting gaps in task performance patterns, nPlan's solution provides statistical risk attribution for individual activities and offers recommendations to mitigate residual issues. This approach allows clients to effectively manage risks and capitalize on opportunities within their construction projects.

Blockchain.com is a digital assets platform that enables users to buy, hold, and utilize cryptocurrency, aiming to create an accessible financial system for the internet. With over 50 million customers, the platform provides a straightforward way to engage with digital currencies, facilitating transactions, trading, and secure storage. It features a highly trafficked explorer for tracking crypto market activities and an exchange that offers a fast trading experience. Blockchain.com is committed to revolutionizing the financial services industry by enabling quick transactions without the need for costly intermediaries, while also providing real-time transaction data and analytical tools for investors and developers.

SpyBiotech Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in the development of innovative vaccines using a proprietary technology known as molecular superglue. This platform allows for the rapid creation of bonding vaccines by attaching antigens to viruses and other particles, enhancing the vaccine development process. By leveraging this unique approach, SpyBiotech aims to provide medical institutions and research centers with more effective vaccines that can be developed in a shorter timeframe, ultimately improving immunity against various diseases, including bacterial infections.

Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

IconOVir Bio is a preclinical-stage biotechnology company focused on developing innovative oncolytic virus therapies for cancer treatment. The company's proprietary platform aims to overcome the limitations associated with first- and second-generation oncolytic viruses, thereby enhancing the therapeutic options available to healthcare professionals. By prioritizing personalized therapy, IconOVir Bio seeks to improve treatment outcomes for cancer patients, positioning itself at the forefront of advancements in oncology.

Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

PostHog is an open-source product analytics platform designed for developers, founded in 2020 and based in San Francisco, California. The platform provides a comprehensive suite of tools that includes product analytics, session recording, funnels, feature flags, and experimentation, all integrated into a single solution. By automating event tracking and user data collection, PostHog enables engineers to understand product usage and user behavior more effectively. This functionality allows development teams to create applications that are better tailored to their users' needs.

Olive deploys the AI workforce built specifically for healthcare, delivering hospitals and health systems increased revenue, reduced costs, and increased capacity. Olive automates repetitive, high-volume tasks and workflows, monitoring their performance, identifying improvements, and finding opportunities for new work. Olive gives power back to providers through her ever-growing, unparalleled intelligence made up of shared memories, collective wisdom, and global awareness, learning like a network so hospitals never have to solve the same problem twice. Olive was founded in 2012 and is headquartered in Columbus, Ohio.